Vaccine Formulation Institute(Ch)ltd

Vaccine Formulation Institute(Ch)ltd is an organisation in Plan Les Ouates, Switzerland that has taken part in 9 EU-funded projects since 2016, receiving €504k in EU funding.

EU funding received€504k
EU projects9
As coordinator0
Running now5
First EU project2016
Latest project2026
CountrySwitzerland
EU registration (PIC)895740487
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Vaccine Formulation Institute(Ch)ltd's own share of each project, not the project's full budget.

  • Horizon Europe€475k · 6 projects
  • Horizon 2020€29k · 3 projects

Projects

9 EU-funded projects, newest first. Each links to the official record.

  • ISIDORe IIPartner

    INTEGRATED SERVICES FOR INFECTIOUS DISEASE OUTBREAK RESEARCH II

    Horizon Europe · 2026–2029 · Project on CORDIS ↗

    €10ktheir share
  • BAXERNA 2.0Associated partner

    Immunopeptidomics-based Development of Next-Generation Bacterial mRNA Vaccines

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • OptiViVaxAssociated partner

    Optimising a High Efficacy Plasmodium vivax Malaria Vaccine

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • UltiMalVaxAssociated partner

    A Vaccine Targeting Eradication of Malaria

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • TBVAC-HORIZONAssociated partner

    Improving understanding of lung immunity in tuberculosis to establish a diverse, innovative TB vaccine pipeline targeting mucosal immunity

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • ISIDORePartner

    Integrated Services for Infectious Disease Outbreak Research

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €465ktheir share
  • TRANSVAC-DSPartner

    DESIGN STUDY FOR A EUROPEAN VACCINE INFRASTRUCTURE

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €29ktheir share
  • OptiMalVaxPartner

    Optimizing a deployable high efficacy malaria vaccine

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

  • EHVAPartner

    European HIV Vaccine Alliance (EHVA): a EU platform for the discovery and evaluation of novel prophylactic and therapeutic vaccine candidates

    Horizon 2020 · 2016–2023 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • HIV
  • antibiotic resistance
  • immunisation
  • immunology
  • infectious diseases
  • malaria
  • pandemics
  • primatology
  • proteomics
  • structural biology
  • tropical medicine
  • tuberculosis
  • vaccines
  • virology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime